Compare iShares MSCI Malaysia ETF (EWM) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Malaysia ETF vs Revvity Inc — how do they compare? iShares MSCI Malaysia ETF trades at $28.28, while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Revvity Inc pays a 0.24% dividend while iShares MSCI Malaysia ETF pays none, and Revvity Inc is trading nearer its 52-week high, iShares MSCI Malaysia ETF nearer its low. Which is the better fit depends on your goals.
| EWM | RVTY | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $30.42 | $117.75 |
52-Week Low | $24.73 | $82.26 |
Market Cap | — | $12.91B |
Enterprise Value | — | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWM, the iShares MSCI Malaysia ETF, trades at $28.28, up 0.86% today, with a bearish technical signal from moving averages and oscillators neutral. The ETF is heavily weighted in Financials (54%) and Industrials (21%). Recent news highlights Malaysia's data center expansion, semiconductor ambitions, and tourism initiatives as growth drivers, though the country faces energy supply challenges amid rising power demand.
Outlook is mixed: Malaysia's economic initiatives offer potential upside, but energy constraints and concentrated sector exposure pose risks. The ETF provides targeted emerging market access, with investor sentiment cautious due to macroeconomic uncertainties and technical weakness.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Malaysia ETF
EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.
Read more on EWM →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
